Bridging Neurology and Thrombosis: Key Priorities from a New Expert Consensus Report – International Journal of Stroke
International Journal of Stroke shared a post on X:
“New report identifies key research priorities for venous thrombosis and stroke From DVT/PE prevention and PFO-related stroke to cerebral venous thrombosis.”
Title: Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials
Authors: Diana Vikulova, Vanessa Dizonno, Lily Zhou, Johnathon Gorman, Ronda Lun, Katrina Hannah Dizon Ignacio, Cheryl D. Bushnell, Aravind Ganesh, Aristeidis H. Katsanos, Luciano A. Sposato, Sara Db Rosa, Alejandro Fuerte-Hortigon, Diana Aguiar de Sousa, Cheryl Carcel, Nishita Singh, Tony Wan, Bethany Samuelson Bannow, Hetao Bian, Chen Chen, Jonathan M. Coutinho, Andrew M. Demchuk, Darshan Doshi, Mehdi Farhoudi, Ana Catarina Gaspar Fonseca, Vivian Fu, Mirjam R. Heldner, Menglu Ouyang, Emily R. Ramage, Ivy Anne Sebastian, Ronen R. Leker, Craig Anderson, Bijoy Menon, Thalia Shoshana Field
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes